Q-linea AB Sustainability Reports
Q-linea AB is an innovative infection diagnostics company that develops and manufactures automated instruments and consumables for rapid antimicrobial susceptibility testing (rAST). Its flagship platform, ASTar, accelerates the diagnosis and optimal antibiotic treatment of severe infectious diseases like sepsis.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300BXVB4XRM8WSC73
FIGI: BBG00JXRCDX4
7 reports from 2018 to 2025